Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) reported Other Non-Current Assets of $7.1 million for Q4 2025, up 172.63% year-over-year from $2.6 million in Q4 2024, and up 199.44% quarter-over-quarter from $2.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has 3 years of Other Non-Current Assets data on file, last reported at $7.1 million in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $7.1 million, up 172.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.1 million (up 172.63% YoY), and the FY2025 annual result was $1.0 million, down 9.07% from the prior year.
- Other Non-Current Assets grew to $7.1 million in Q4 2025 per ZYBT's latest filing, from $2.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $7.1 million in Q4 2025 and troughed at $624576.6 in Q4 2023.
- A 3-year average of $3.2 million and a median of $2.5 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets jumped 316.77% in 2024, then soared 172.63% in 2025.
- A 3-year view of Other Non-Current Assets shows it stood at $624576.6 in 2023, then surged by 316.77% to $2.6 million in 2024, then soared by 172.63% to $7.1 million in 2025.
- Business Quant data shows ZYBT's Other Non-Current Assets at $7.1 million in Q4 2025, $2.4 million in Q2 2025, and $2.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Zhengye Biotechnology Holding | 5.49 Mn | 6.20 Mn | - | 7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.10 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 624,576.61 |